William W. Barrow

Use of Microsphere Technology for Targeted Delivery of Rifampin to <i>Mycobacterium tuberculosis</i> -Infected Macrophages

Esther L. W. Barrow, Gary A. Winchester, Jay K. Staas et al. · Antimicrobial Agents and Chemotherapy · 1998 · 113 citations · Full text

Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis

Ze‐Qi Xu, William W. Barrow, William J. Suling et al. · Bioorganic & Medicinal Chemistry · 2004 · 103 citations

Pulmonary Tuberculosis, Antiviral Compound, Health Sciences +13

Peptidoglycolipid nature of the superficial cell wall sheath of smooth-colony-forming mycobacteria

William W. Barrow, B P Ullom, Patrick J. Brennan · Journal of Bacteriology · 1980 · 91 citations · Full text

Medical Microbiology, Smooth-colony-forming Mycobacteria, Gram-negative Bacteriology +15

Synergistic activities of antituberculous drugs with cerulenin and<i>trans</i>-cinnamic acid against<i>Mycobacterium tuberculosis</i>

Nalin Rastogi, Khye Seng Goh, Lionel Horgen et al. · FEMS Immunology & Medical Microbiology · 1998 · 87 citations

Tuberculosis Prevention, Antimicrobial Chemotherapy, Drug Resistance +18

Isolation in high frequency of rough variants of Mycobacterium intracellulare lacking C-mycoside glycopeptidolipid antigens

William W. Barrow, Patrick J. Brennan · Journal of Bacteriology · 1982 · 83 citations · Full text

Biology, Medical Microbiology, Rough Morphology +12